Who owns Glycomimetics?
- Ticker: GLYC
- CUSIP Number: 38000q102
Tip: Access positions for across all investors
Analyze quarterly positions in Glycomimetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Glycomimetics stock
Who bought or sold Glycomimetics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 9.5M | $1.6M | 0% | Sep 2024 |
|
| Vanguard Group | 2.7M | $759k | -2% | Jun 2024 |
|
| Siren | 2.0M | $332k | 100% | Sep 2024 |
|
| Goldman Sachs Group | 804k | $227k | -28% | Jun 2024 |
|
| Renaissance Technologies | 781k | $132k | -6% | Sep 2024 |
|
| BlackRock | 728k | $123k | 100% | Sep 2024 |
|
| BlackRock | 723k | $204k | -1% | Jun 2024 |
|
| Balyasny Asset Management | 650k | $183k | 75% | Jun 2024 |
|
| Geode Capital Management | 521k | $88k | 7% | Sep 2024 |
|
| Acadian Asset Management | 357k | $59k | -33% | Sep 2024 |
|
| State Street Corporation | 179k | $51k | 0% | Jun 2024 |
|
| Northern Trust | 117k | $20k | -9% | Sep 2024 |
|
| Two Sigma Advisers | 109k | $31k | 271% | Jun 2024 |
|
| HCR Wealth Advisors | 100k | $17k | 100% | Sep 2024 |
|
| GSA Capital Partners | 84k | $14k | 100% | Sep 2024 |
|
| Bridgeway Capital Management | 82k | $23k | -51% | Jun 2024 |
|
| Intellectus Partners | 46k | $7.8k | 0% | Sep 2024 |
|
| Ieq Capital | 38k | $11k | 0% | Jun 2024 |
|
| Group One Trading | 38k | $6.4k | -42% | Sep 2024 |
|
| Hrt Financial | 32k | $5.0k | -32% | Sep 2024 |
|
| LPL Financial | 31k | $5.2k | 6% | Sep 2024 |
|
| Virtu Financial | 20k | $3.0k | 100% | Sep 2024 |
|
| Tobias Financial Advisors | 15k | $2.5k | 0% | Sep 2024 |
|
| Pine Valley Investments Ltd Liability | 13k | $2.1k | 100% | Sep 2024 |
|
| Jump Financial | 12k | $1.9k | 100% | Sep 2024 |
|
| Baader Bank | 11k | $1.3k | 100% | Sep 2024 |
|
| Morgan Stanley | 5.2k | $1.5k | -95% | Jun 2024 |
|
| EverSource Wealth Advisors | 4.8k | $804.070500 | 0% | Sep 2024 |
|
| Royal Bank of Canada | 2.0k | $0 | -14% | Sep 2024 |
|
| Qube Research & Technologies | 1.1k | $309.270900 | -100% | Jun 2024 |
|
| Bnp Paribas Arbitrage, Snc | 481.00 | $81.000400 | 0% | Sep 2024 |
|
| Bank of America Corporation | 464.00 | $77.998400 | -91% | Sep 2024 |
|
| Jpmorgan Chase & Co | 141.00 | $23.998200 | -7% | Sep 2024 |
|
| Barclays | 76.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Glycomimetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Artal Group | Jun 2024 | 8.6M | $2.4M |
| Susquehanna International | Jun 2024 | 1.2M | $328k |
| Millennium Management | Jun 2024 | 186k | $52k |
| Verition Fund Management | Mar 2024 | 162k | $487k |
| Sargent Investment Group | Jun 2024 | 100k | $28k |
| Torno Capital | Jun 2024 | 75k | $21k |
| Citadel Advisors | Jun 2024 | 67k | $19k |
| Letko, Brosseau & Associates | Jun 2024 | 45k | $13k |
| Leucadia National Corporation | Mar 2024 | 38k | $115k |
| ExodusPoint Capital Management | Mar 2024 | 36k | $107k |
| OMERS Administration Corporation | Mar 2024 | 31k | $92k |
| Jane Street | Jun 2024 | 30k | $8.4k |
| Tower Research Capital | Mar 2024 | 24k | $71k |
| Squarepoint Ops | Mar 2024 | 20k | $61k |
| LMR Partners | Jun 2024 | 15k | $4.1k |
| Truvestments Capital | Mar 2024 | 2.1k | $6.2k |
| Macquarie Group | Mar 2024 | 1.9k | $6.010900 |
| Rhumbline Advisers | Jun 2024 | 1.0k | $293.990400 |
| National Bank Of Canada /fi/ | Jun 2024 | 600.00 | $177.000000 |